The Hospital-based Monitoring for Adverse Drug Reactions of Xiangxue Kangbingdu Oral Liquid

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONC-13004007

Enrollment

Unknown

Registered

2013-12-17

Start date

2012-05-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of Xiangxue Kangbingdu Oral Liquid applications

Interventions

observational group:Xiangxue Kangbingdu Oral Liquid

Eligibility

Sex/Gender

All

Age

1 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. All the outpatients that used Xiangxue Kangbingdu Oral Liquid in hospital information systems; 2. Patients that voluntarily accepted investigation; 3. Completed at least one follow-up or visit.

Exclusion criteria

Exclusion criteria: no

Design outcomes

Primary

Measure	Time frame
Incidence of adverse drug reaction;	—

Countries

China

Contacts

Public ContactZehuai Wen

Guangdong Provincial Hospital of Chinese Medicine

wenzehuai@139.com+86 13903008091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026